Sumycin

Acinetobacter Infections, Rocky Mountain Spotted Fever, Psittacosis + 46 more
Treatment
64 FDA approvals
20 Active Studies for Sumycin

What is Sumycin

TetracyclineThe Generic name of this drug
Treatment SummaryTetracycline is an antibiotic used to treat bacterial infections. It works by preventing bacteria from making proteins necessary for their growth. Tetracycline binds to the ribosomes, which are components of the bacterial cell, and causes them to leak, leading to the death of the bacteria.
Tetracycline Hydrochlorideis the brand name
image of different drug pills on a surface
Sumycin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Tetracycline Hydrochloride
Tetracycline
1975
59

Approved as Treatment by the FDA

Tetracycline, also known as Tetracycline Hydrochloride, is approved by the FDA for 64 uses which include Lower respiratory tract infection bacterial and Campylobacter Infections .
Lower respiratory tract infection bacterial
Campylobacter Infections
Bacteria
Acinetobacter Infections
Chlamydia Infections
Bacterial Infections
Tularemia
Bacterial Infections
Clostridium Infections
Severe Acne
Escherichia infections
Trachoma
Anthrax disease
Inclusion conjunctivitis
Relapsing Fever
Brucellosis
Necrotizing ulcerative gingivostomatitis
Entamoeba histolytica Infection
Neisseria Gonorrhoeae Infection
Psittacosis
Klebsiella Infections
Brucellosis
Disease
Bacteria
Q Fever
Plague
Conjunctivitis, Inclusion
Relapsing Fever
Listeriosis
Gonorrhea
Yaws
Acne Vulgaris
Syphilis
Cholera (Disorder)
Fever
Urinary Tract Infections
Dysentery, Bacillary
Urinary Tract Infection (UTI)
Typhus
Infection, Bacteroides
Campylobacter Infection
Granuloma Inguinale
Trachoma
Clostridium difficile Infection
Listeria infection
Cat-Scratch Disease
Upper respiratory tract infection bacterial
Helicobacter Pylori Infection
Used to treat Helicobacter Pylori Infection in combination with Metronidazole
Acinetobacter Infections
Yaws
Plague
Chlamydial Infections
Tularemia
Ornithosis
Escherichia coli Infections
Anthrax
Chancroid
Skin Infections caused by Staphylococcus Aureus
Actinomycosis
Shigella Infection
Lymphogranuloma Venereum
Rickettsialpox
Rocky Mountain Spotted Fever
Skin and Subcutaneous Tissue Bacterial Infections

Effectiveness

How Sumycin Affects PatientsTetracycline is a short-term antibiotic that works by blocking the ability of bacteria to make proteins. It does this by attaching to parts of the bacteria's cells, which prevents the bacteria from making the proteins it needs to survive. Tetracycline can also weaken the outer membrane of the bacteria, causing it to leak out important molecules it needs to survive.
How Sumycin works in the bodyTetracycline works by blocking the production of proteins in bacteria. It enters the bacterial cells and binds to their ribosomes, preventing tRNA molecules from translating the genetic code into proteins. This stops the bacteria from making proteins, which kills them.

When to interrupt dosage

The proposed measure of Sumycin is contingent upon the diagnosed affliction, including Bartonellosis, Skin Infections induced by Staphylococcus Aureus and Clostridium difficile Infection (CDI). The amount of dosage relies upon the method of administration detailed in the table beneath.
Condition
Dosage
Administration
Anthrax
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Syphilis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Rocky Mountain Spotted Fever
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Trachoma
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Acute Glomerulonephritis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Urinary tract infection
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Cat-Scratch Disease
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Brucellosis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Bacteria
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Bacteria
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Actinomycosis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Rosacea
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Helicobacter Pylori Infection
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Ornithosis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Clostridium difficile Infection
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Entamoeba histolytica Infection
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Urinary Tract Infections
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Listeriosis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Bacterial Infections
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray
Necrotizing ulcerative gingivostomatitis
, 250.0 mg, 500.0 mg, 30.0 mg/mL, 0.03 mg/mL, 0.03 mg/mg, 125.0 mg, 1.0 %, 12.7 mg, 1.5 mg/mg, 125.0 mg/mL, 0.01 mg/mg
Oral, Capsule - Oral, Capsule, , Ointment, Ointment - Topical, Topical, Kit - Oral, Kit, Ointment - Ophthalmic, Ophthalmic, Tablet, Tablet - Oral, Liquid - Oral, Liquid, Dental, Tablet, film coated, Tablet, film coated - Oral, Syrup, Syrup - Oral, Spray - Topical, Spray

Warnings

There are 20 known major drug interactions with Sumycin.
Common Sumycin Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Tetracycline.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Tetracycline.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Tetracycline.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Tetracycline.
Amdinocillin
Major
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Tetracycline.
Sumycin Toxicity & Overdose RiskThe lethal dose of the drug in mice when taken orally is 808mg/kg.
image of a doctor in a lab doing drug, clinical research

Sumycin Novel Uses: Which Conditions Have a Clinical Trial Featuring Sumycin?

45 active trials are investigating the potential of Sumycin in the management of Klebsiella Infections, Rocky Mountain Spotted Fever and Granuloma Inguinale.
Condition
Clinical Trials
Trial Phases
Chancroid
0 Actively Recruiting
Escherichia coli Infections
5 Actively Recruiting
Not Applicable, Phase 2, Phase 1
Rickettsialpox
0 Actively Recruiting
Rosacea
2 Actively Recruiting
Early Phase 1, Phase 2
Clostridium difficile Infection
0 Actively Recruiting
Listeriosis
0 Actively Recruiting
Dysentery, Bacillary
0 Actively Recruiting
Campylobacter Infections
0 Actively Recruiting
Plague
0 Actively Recruiting
Trachoma
1 Actively Recruiting
Phase 4
Infection
6 Actively Recruiting
Not Applicable, Phase 1
Bacteria
0 Actively Recruiting
Psittacosis
0 Actively Recruiting
Klebsiella Infections
0 Actively Recruiting
Rocky Mountain Spotted Fever
0 Actively Recruiting
Relapsing Fever
0 Actively Recruiting
Prostatitis
0 Actively Recruiting
Tularemia
0 Actively Recruiting
Granuloma Inguinale
0 Actively Recruiting
Cat-Scratch Disease
0 Actively Recruiting

Sumycin Reviews: What are patients saying about Sumycin?

3Patient Review
9/21/2012
Sumycin for Sepsis Caused by Bacteria
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about sumycin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which drugs are tetracyclines?

"Adoxa, Adoxa CK, Adoxa Pak, Brodspec, Cleeravue-M, Declomycin, Doryx, and Dynacin are all medicines."

Answered by AI

How do you take sumycin?

"An adult dose of Sumycin is 1 gram (g), taken four times a day for 7 to 10 days. A child's dose of Sumycin is based on weight.

How to use Sumycin Tablet:

Tetracycline works best when taken on an empty stomach 1 hour before or 2 hours after meals. If stomach upset occurs, ask your doctor if you can take this medication with food.

Take each dose with a full glass of water (8 ounces or 240 milliliters) unless your doctor directs you otherwise.

An adult dose of Sumycin is 1 gram (g), taken four times a day for 7 to 10 days. A child's dose of Sumycin is based on weight."

Answered by AI

What is the most common side effect of tetracyclines?

"If you experience any of the following side effects, tell your doctor or pharmacist immediately as they may worsen over time. These include: nausea, vomiting, diarrhea, loss of appetite, mouth sores, black hairy tongue, sore throat, dizziness, headache, or rectal discomfort."

Answered by AI

What is sumycin used for?

"Tetracycline hydrochloride, sold under the brand name Sumycin among others, is an antibiotic used to treat a number of infections. This includes acne, chlamydia, gonorrhea, urinary tract infections, and others. It is taken by mouth."

Answered by AI

Clinical Trials for Sumycin

Image of Baylor College of Medicine in Houston, United States.

Educational Tool for Urinary Tract Infections

18+
All Sexes
Houston, TX
Urine culture is the most common microbiological test in the outpatient setting in the United States. Unfortunately, contamination during collection is prevalent and undermines test accuracy, leading to incorrect diagnosis, unnecessary treatment, wasted laboratory resources, and inflated costs. Unnecessary antibiotic treatment increases the risk of developing antimicrobial resistance, one of the most serious threats to patients and public health. The goal of this clinical trial is to test whether a bilingual (English and Spanish) educational intervention, an animated video and pictorial flyer, can reduce urine culture contamination and associated inappropriate antibiotic use in adult patients visiting safety-net primary care clinics. The main questions it aims to answer are: 1. Does providing patients with a bilingual educational intervention reduce urine culture contamination rates? 2. Does the intervention lead to fewer unnecessary urinary antibiotic prescriptions? 3. Does providing patients with a bilingual educational intervention reduce contaminated urinalyses? Researchers will compare patients randomized to receive the educational intervention (video and flyer) to those receiving usual care to see if the intervention improves urine collection accuracy and reduces inappropriate antibiotic use. Participants will watch a short, animated video with step-by-step instructions for proper midstream clean-catch urine (MSCC) collection, receive a pictorial flyer (with stills from the video) reinforcing the instructions, and provide a urine sample for culture. Hypothesis: patients who receive the educational intervention will have: lower urine culture contamination rates (primary outcome), fewer urinary antibiotic prescriptions (secondary outcome), and fewer contaminated urinalyses (secondary outcome). The objectives are to (1) develop educational tools: Create an animated video and pictorial flyer with step-by-step urine collection instructions for women and men, developed through an iterative, stakeholder-engaged process, (2) assess acceptability: Use mixed methods (quantitative surveys and qualitative interviews) to evaluate and refine the tools for usability and cultural/linguistic appropriateness, and (3) test effectiveness: Conduct a randomized controlled trial to assess the intervention's impact on urine contamination rates, antibiotic prescribing, and patient satisfaction.
Waitlist Available
Has No Placebo
Baylor College of MedicineLarissa Grigoryan, MD, PhD
Image of UPMC Magee-Womens Hospital in Pittsburgh, United States.

Catheterization Methods for Postpartum Urinary Problems

18+
All Sexes
Pittsburgh, PA
At least ten percent of patients have postpartum urinary retention or difficulty urinating after birth, which can cause incontinence and other urinary problems long-term. After getting an epidural placed, patients should be numb in their pelvic region. This numbness makes it difficult to feel the need to urinate, so patients need a urinary catheter placed to empty the bladder. Some patients have one catheter placed throughout their labor and others have a catheter placed to empty the bladder then removed every few hours. The investigators are studying whether placing a catheter once or catheterizing multiple times affects the rate of postpartum urinary problems and infection.
Waitlist Available
Has No Placebo
UPMC Magee-Womens HospitalAnna Binstock, MD
Have you considered Sumycin clinical trials? We made a collection of clinical trials featuring Sumycin, we think they might fit your search criteria.Go to Trials
Image of Queens Medical Center, 1004 Clinic POB1 in Honolulu, United States.

Self-swab Testing for STDs

Any Age
Female
Honolulu, HI
The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are: What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision? How does the uptake of such a service among patients receiving telemedicine abortion care compare to the population of patients who seek in-person medication abortion care? What are the positivity rates for STIs in among patients receiving telemedicine medication abortion care compared to the positivity rates for a contemporaneous, in-clinic population? What is the average time to between testing and treatment for patients who test positive for an STI using the self-collection service? Researchers will compare the intervention group to a contemporaneous, in-clinic population on uptake of STI screening, as well as on positivity rates for the STIs tested. Participants will be asked to perform self-swab collection for STI testing for gonorrhea, chlamydia, and trichomonas. They will be instructed to send their specimens to a lab using prepaid postage. Upon completion of sample collection and shipping, they will be asked to complete a survey assessing basic demographic information, as well as acceptability and feasibility of the intervention. Patients who test positive for an STI will be promptly provided/referred to treatment.
Recruiting
Has No Placebo
Queens Medical Center, 1004 Clinic POB1
Have you considered Sumycin clinical trials? We made a collection of clinical trials featuring Sumycin, we think they might fit your search criteria.Go to Trials
Image of Maternity Centre of Hamilton in Hamilton, Canada.

Rapid Test for Syphilis

13 - 49
All Sexes
Hamilton, Canada
The goal of this clinical trial is to learn if a finger-prick blood test for rapid diagnosis of syphilis infection can be implemented in a low-barrier prenatal clinic for people at risk of syphilis in pregnancy. The test gives results in 5 minutes and also tests for HIV. The main questions the study aims to answer are: * How often do pregnant people at risk of syphilis agree to the rapid test? * How well do healthcare providers perform the rapid test? * Does the rapid test speed up diagnosis and treatment of syphilis in pregnant people and their sexual partners? Participants will: * Give feedback about why they did or did not want to take the rapid test, and what their experience was taking the test; and * Share information about their health, pregnancy, and syphilis treatment (if applicable).
Recruiting
Has No Placebo
Maternity Centre of HamiltonLaura K Erdman, MD PhD FRCPC
Image of Atlantic Health in Morristown, United States.

Methenamine for Urinary Tract Infection

18 - 100
Female
Morristown, NJ
Stress urinary incontinence (SUI) affects at least 40% of women in the United States. Synthetic polypropylene mid-urethral slings (MUS) are the gold standard treatment for SUI. Post-operative urinary tract infections (UTI) are one of the most common complications after MUS placement. Some studies have demonstrated that MUS placement can increase the risk of UTI up to 21-34%. Post-operative UTI can lead to significant healthcare and patient burden. This additional burden further contributes to an estimated annual cost of $1.6 billion for UTI management in the United States. With increased antibiotic usage, there is simultaneous increase in bacterial resistance leading to treatment refractory UTI. The investigators prescribe post-operative antibiotics prophylactically for 3 days after MUS placement with or without concurrent pelvic reconstructive surgery based on prior literature recommending post-operative prophylaxis. There is a greater emphasis on limiting antibiotic use given the trend of development of bacterial resistance. There are studies supporting alternatives such as methenamine for recurrent UTI prophylaxis treatment, but there are limited studies evaluating methenamine for UTI prophylaxis after MUS.
Recruiting
Has No Placebo
Atlantic Health
Have you considered Sumycin clinical trials? We made a collection of clinical trials featuring Sumycin, we think they might fit your search criteria.Go to Trials